BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18384073)

  • 1. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
    Granholm S; Lundberg P; Lerner UH
    J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D; Cornish J
    Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis.
    Granholm S; Henning P; Lerner UH
    J Cell Biochem; 2011 Nov; 112(11):3300-12. PubMed ID: 21748786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
    Lerner UH
    J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.
    Yamamoto Y; Yamamoto Y; Udagawa N; Okumura S; Mizoguchi T; Take I; Yamauchi H; Yamauchi H; Noguchi T; Takahashi N
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(3):25-31. PubMed ID: 17535751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
    Thota C; Gangula PR; Dong YL; Yallampalli C
    Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclast-like cells express receptor activity modifying protein 2: application of laser capture microdissection.
    Nakamura M; Morimoto S; Yang Q; Hisamatsu T; Hanai N; Nakamura Y; Mori I; Kakudo K
    J Mol Endocrinol; 2005 Feb; 34(1):257-61. PubMed ID: 15691893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
    Pan ChS; Jiang W; Wu ShY; Zhao J; Pang YZ; Tang ChS; Qi YF
    Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
    Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
    Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3'5'-monophosphate generation in Eker rat uterine smooth muscle cell line.
    Thota C; Yallampalli C
    Biol Reprod; 2005 Feb; 72(2):416-22. PubMed ID: 15469997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
    Born W; Muff R; Fischer JA
    Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
    Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
    J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
    Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
    Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
    Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
    Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines.
    Wunder F; Rebmann A; Geerts A; Kalthof B
    Mol Pharmacol; 2008 Apr; 73(4):1235-43. PubMed ID: 18174292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
    Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel member of the calcitonin gene-related peptide family, calcitonin receptor-stimulating peptide, inhibits the formation and activity of osteoclasts.
    Notoya M; Arai R; Katafuchi T; Minamino N; Hagiwara H
    Eur J Pharmacol; 2007 Apr; 560(2-3):234-9. PubMed ID: 17328890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
    Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
    J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.